Skip to main content

Research Repository

Advanced Search

Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists

Crabtree, Thomas S. J.; Adamson, Karen; Reid, Hazel; Barnes, Dennis; Sivappriyan, Siva; Bickerton, Alex; Gallen, Ian W.; Field, Benjamin C. T.; Idris, Iskandar; Ryder, Robert E. J.

Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists Thumbnail


Authors

Thomas S. J. Crabtree

Karen Adamson

Hazel Reid

Dennis Barnes

Siva Sivappriyan

Alex Bickerton

Ian W. Gallen

Benjamin C. T. Field

ISKANDAR IDRIS Iskandar.Idris@nottingham.ac.uk
Professor of Diabetes and Metabolic Medicine

Robert E. J. Ryder



Abstract

The ABCD semaglutide audit was designed to capture the routine clinical outcomes of people commenced on semaglutide in the UK. Previous work showed differential reductions in HbA1c and weight dependent on previous glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure. The analysis, in this research letter, shows that decreases in HbA1c and weight associated with semaglutide occur irrespective of previous GLP-1RA use. However, HbA1c reductions were less if switched from dulaglutide or liraglutide and weight changes were attenuated if switched from dulaglutide or exenatide, potentially suggesting differing potencies between GLP-1RAs. Dedicated studies with head-to-head comparisons are needed to confirm these findings.

Citation

Crabtree, T. S. J., Adamson, K., Reid, H., Barnes, D., Sivappriyan, S., Bickerton, A., …Ryder, R. E. J. (2022). Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon-like peptide-1 receptor agonists. Diabetes, Obesity and Metabolism, 24(7), 1398-1401. https://doi.org/10.1111/dom.14701

Journal Article Type Article
Acceptance Date Mar 22, 2022
Online Publication Date Apr 7, 2022
Publication Date 2022-07
Deposit Date Apr 22, 2022
Publicly Available Date Apr 22, 2022
Journal Diabetes, Obesity and Metabolism
Print ISSN 1462-8902
Electronic ISSN 1463-1326
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 24
Issue 7
Pages 1398-1401
DOI https://doi.org/10.1111/dom.14701
Keywords Endocrinology; Endocrinology, Diabetes and Metabolism; Internal Medicine
Public URL https://nottingham-repository.worktribe.com/output/7786064
Publisher URL https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14701

Files




You might also like



Downloadable Citations